Growers of red clover could pick up a premium market for the crop if an Edmonton “natural health” company’s osteoporosis treatment makes it to the commercial stage. SinoVeda Canada, which recently picked up a $2.9 million investment from Calgary venture capital fund Avac Ltd. for the company’s “pre-commercial development,” would use component chemicals from the crop in its proposed treatment. It’s also working on an angina treatment from traditional Chinese herbs and a calcium supplement to be extracted from cultured pearls.
Farmfair offers exhibitors rapid COVID test, refund guarantee
New campaign will stand up for lowly ditches and hidden rights-of-way
It’s not just about the tractor anymore
Timing key when managing high-nitrate feeds